Impala Platinum Could Shed Close to 4,000 Jobs Amid Price Rout
By Christian Moess Laursen
Impala Platinum could lay off around 3,900 workers to save costs and improve operational efficiency in response to a platinum price rout and persistent cost inflation ripping through the sector.
The South African miner--the world's second-biggest platinum producer--said Friday that a proposed restructuring could affect 9% of the labor workforce across its Rustenburg, Bakofeng and Marula operations, as result in a 30% reduction in head office costs.
The measures are aimed at optimizing operational efficiencies and resources, as well as to ensure that each of its business units contributes sustainably and profitably through the fluctuations of platinum-group metals cycles, it said.
The company, also known as Implats, cited sharply declining PGM prices and persistent inflationary pressures squeezing its profitability and cash flow, while global macroeconomic uncertainty and rising geopolitical tensions have added to its headwinds.
Write to Christian Moess Laursen at christian.moess@wsj.com
(END) Dow Jones Newswires
April 26, 2024 06:48 ET (10:48 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
Markets Brief: Is It Really a Surprising Quarter for Earnings?
-
After Earnings, Is Berkshire Hathaway Stock a Buy, a Sell, or Fairly Valued?
-
For Bond Investors, Delayed Rate Cuts Demand a Different Playbook
-
What’s Happening In the Markets This Week
-
How the Tokyo Stock Exchange Is Pushing for Better Shareholder Returns
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
The 10 Best Dividend Stocks
-
3 Stocks With High Dividend Yields That Warren Buffett Likes
-
How to Invest Like Warren Buffett
-
Berkshire Hathaway Earnings: Strong Insurance Results Continue to Lift Revenue and Profitability
-
10 Questions for Berkshire Hathaway’s 2024 Annual Meeting
-
After Earnings, Is Ford Stock a Buy, a Sell, or Fairly Valued?
-
3 Dividend Stocks for May 2024
-
Amgen Earnings: Obesity Drug Update Is Highly Encouraging